China – Submission for Cosmetic Ingredients Safety is Now Operating
NMPA has officially launched the platform for the submission of cosmetic ingredients safety information. On this platform, Chinese manufacturers or authorized companies log in and submit information on ingredient safety.
Marta Pinto

Marta Pinto

Regulatory Affairs Associate

CHINESE COSMETICS REGULATION

The implementation of a new Cosmetics Supervision and Administration Regulation (CSAR) has come into force on 1st of January (2021). A pre-market approval system on new cosmetic and new ingredients was implemented in the country and seven important regulations have come into effect: Administrative Measures on Cosmetics Registration and Notification; Provisions for Management of Cosmetic Registration and Notification Dossiers; Provisions for Management of New Cosmetic Ingredient Registration and Notification Dossiers; Cosmetic Classification Rules and Catalogs; Standards for Cosmetic Efficacy Claim Evaluation; Technical Guidelines for Cosmetic Safety Assessment 2021; Inventory of Existing Cosmetic Ingredients in China 2021. (see previous post)

Last year, the National Medical Products Administration (NMPA) released the final versions of the two regulations: Provisions for Management of Cosmetic Registration and Notifications Dossiers (previously called as Instructions for Cosmetic Registration and Notification Dossiers) and Provisions for Management of New Cosmetic Ingredient Registration and Notifications Dossiers. The key goal of such regulations is to standardize and guide the registration and filing of new cosmetic materials and products. The documentation requirements for application, modification, renewal and cancellation of a cosmetic registration and notification are specified on these regulations. (see previous post)

Cosmetics will be classified according to a coding system set out by the Cosmetic Classification Rules and Catalogs. Detailed requirements for qualification for safety assessors, safety assessments and the content in the report are clarified in the Technical Guidelines for Cosmetic Safety Assessment 2021. (see previous post)

SUBMISSION PLATFORM FOR COSMETIC INGREDIENTS SAFETY INFORMATION

NMPA has officially launched the platform for the submission of cosmetic ingredients safety information. On this platform, manufacturers or authorized companies log in and submit information on ingredient safety.

In order to help companies to use the platform correctly and standardize the submissions a Technical Guidance for Submission of Cosmetic Ingredients Safety Information (translation to English is pending) was published.

Spot-checks of the information submitted in the platform will be done by the NMPA. General cosmetics containing skin-brightening ingredients (e.g., phenethyl resorcinol, which is banned) are at this moment the primary focus.

Recently, the NMPA issued a science article which indicated that a draft list of permitted cosmetic whitening agents is being prepared. This will have influence on the definition of whitening cosmetics in the country.

The Chinese legal framework on cosmetics can be tricky and hard to understand, but Critical Catalyst has a team of experts that can help you. Please feel free to contact us using our email info@criticalcatalyst.com.

References:

  1. China to Release a List of Permitted Cosmetic Whitening Ingredients. Chemlinked. Dec 22, 2021. Available at: https://cosmetic.chemlinked.com/news/cosmetic-news/china-to-release-a-list-of-permitted-cosmetic-whitening-ingredients
  2. Breaking! China Launches the Long-Awaited Submission Platform for Cosmetic Ingredients Safety Information. Chemlinked. Dec 31, 2021. Available at: https://cosmetic.chemlinked.com/news/cosmetic-news/breaking-china-launches-the-long-awaited-submission-platform-for-cosmetic-ingredients-safety-information?utm_source=edm

further
reading

cosmetic products

The Responsible Person in the EU

Only cosmetic products for which a Responsible Person is designated in the European Union can be placed on the EU market. The Responsible Person must ensure full compliance with the European Cosmetic Regulation.

Read More »
cosmetic products

SCCS Preliminary Opinion on Genistein and Daidzein

The European Commission Scientific Committee on Consumer Safety (SCCS) has published its preliminary opinion on the use of Genistein and Daidzein in cosmetic products. The deadline for comments was set at 14 March 2022.

Read More »
cosmetic products

The Cosmetic Products Notification Portal (CPNP)

Only cosmetic products for which a legal or natural person is designated within the EU as a “Responsible Person” can be placed on the European Union (EU) market. Before placing a cosmetic product on the EU market, the RP must notify it in the Cosmetic Products Notification Portal (CPNP).

Read More »
cosmetic products

French Anti-Waste Law

The Loi relative à la lute contre le gaspillage et a l’économie circulaire (Anti-Waste for a circular economy) has come officially into force in France in 2020. Since the beginning of this year, some requirements of the law became mandatory, like the Triman logo. The law provides for a ban on all single-use plastics by 2040.

Read More »
cosmetic products

SCCS Preliminary Opinion on 4-MBC

In 2019, the European Commission set out two lists of ingredients suspected of having endocrine disrupting properties. As 4-MBC (UV-filter) was included in the higher priority group, the European Commission asked the SCCS to carry out a safety assessment on this ingredient. The preliminary version of the requested opinion was published.

Read More »
cosmetic products

SCCS Revision of the Opinion on Vitamin A

Vitamin A is not currently included in the Annexes of the European Cosmetics Regulation (Regulation (EC) No 1223/2009). The SCCS published the preliminary version of its revision of the scientific opinion on Vitamin A (retinol, retinyl palmitate and retinyl acetate). The deadline for comments was set at 7 February.

Read More »
medical devices

Person Responsible for Regulatory Compliance (PPRC) under MDR & IVDR

The EU Medical Device Regulation (EU MDR) and the EU In Vitro Diagnostic Device Regulation (EU IVDR) require all Manufacturers and Authorized Representatives to have a designated employee in their company who is responsible for regulatory compliance with the applicable MDR or IVDR requirements, the Person Responsible for Regulatory Compliance (PRRC).

Read More »